Literature DB >> 17963922

Bilateral subthalamotomy for advanced Parkinson disease.

Ham-Min Tseng1, Philip C Su, Hon-Man Liu, Horng-Huei Liou, Ruoh-Fang Yen.   

Abstract

BACKGROUND: Unilateral subthalamotomy has been reported to be effective in the treatment of rigidity, bradykinesia, and tremor of the contralateral limb. However, gait, clinical fluctuation, and postural stability are not significantly improved by unilateral lesioning of the STN in the long term. We sought to determine if bilateral surgery of the STN offers more benefits in the treatment of advanced PD.
METHODS: Radiofrequency thermal coagulation was performed bilaterally in the STN in 10 patients. Under microelectrode and stereotactic guidance, surgery was directed at the dorsolateral portion of the STN in stages and followed by MRI in each patient to confirm lesion location. Patients have been followed for a median duration of 26 months as measured from the date of first surgery (range, 6-48 months) with UPDRS before and after surgery.
RESULTS: Bilateral subthalamotomy demonstrated persistent benefits in bradykinesia, rigidity of the limbs, and consequently the improvement in activities of daily living, motor function, Schwab and England scales. In addition, significant improvement in axial motor features, gait, postural stability, and clinical fluctuation were present with bilateral STN surgeries. The benefits were sustained at the last evaluation period of 36 months. Tremor and drug-induced dyskinesia improved in early postoperative period, but the benefits declined over time. The reduction of daily l-dopa equivalent was 34%. No speech impairment was observed. Mild choreic movement occurred in 2 of 20 procedures that resolved spontaneously in 4 to 8 weeks.
CONCLUSION: For advanced PD present with bilateral symptoms, axial motor impairment, or clinical fluctuation, staged bilateral subthalamotomy appears as a safe and effective treatment in the long term.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963922     DOI: 10.1016/j.surneu.2007.05.058

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 2.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

Review 3.  The T-type calcium channel as a new therapeutic target for Parkinson's disease.

Authors:  Ya-Chin Yang; Chun-Hwei Tai; Ming-Kai Pan; Chung-Chin Kuo
Journal:  Pflugers Arch       Date:  2014-02-18       Impact factor: 3.657

4.  The Role of Focused Ultrasound in the Management of Movement Disorders: Insights after 5 Years of Experience.

Authors:  Raúl Martínez-Fernández; Michele Matarazzo; Jorge U Máñez-Miró; Jose A Obeso
Journal:  Mov Disord Clin Pract       Date:  2021-04-23

Review 5.  Subthalamic nucleus and globus pallidus internus stimulation for the treatment of Parkinson's disease: A systematic review.

Authors:  Hao Xu; Feng Zheng; Boris Krischek; Wanhai Ding; Chi Xiong; Xin Wang; Chaoshi Niu
Journal:  J Int Med Res       Date:  2017-07-12       Impact factor: 1.671

6.  Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model.

Authors:  Deyu Zheng; Xiaohua Jiang; Junpeng Zhao; Deyi Duan; Huanying Zhao; Qunyuan Xu
Journal:  Neural Plast       Date:  2013-04-29       Impact factor: 3.599

7.  Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.

Authors:  Rodolphe Hajj; Aude Milet; Damien Toulorge; Nathalie Cholet; Julien Laffaire; Julie Foucquier; Sandra Robelet; Richard Mitry; Mickael Guedj; Serguei Nabirotchkin; Ilya Chumakov; Daniel Cohen
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

Review 8.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.